Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.45 |
| ▸ | PIN1 | Q13526 | 6/20 | 0.44 |
| ▸ | BRAF | P15056 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 4/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 3/20 | 0.43 |
| ▸ | MGMT | P16455 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL72543 | 0.79 | CDK2 (0.62) | PDPK1GDAPIN1CYP1A2CYP2D6 | |
| SCHEMBL30523413 | 0.79 | CDK1 (0.67) | BRAFCDK1NUDT1 | |
| SCHEMBL16145984 | 0.79 | CDK1 (0.67) | BRAFCDK1NUDT1 | |
| Hydrochloric Acid SCHEMBL27818634 | 0.78 | CDK2 (0.60) | PDPK1GDAPIN1CYP1A2CYP2D6 | |
| SCHEMBL27886988 | 0.78 | CDK2 (0.60) | PDPK1GDAPIN1CYP1A2CYP2D6 | |
| Alcohol SCHEMBL27857990 | 0.76 | PIN1 (0.55) | PDPK1GDAPIN1BRAFCYP1A2 | |
| SCHEMBL31642104 | 0.74 | PDPK1 (0.59) | PDPK1GDAPIN1CDK2DPP4 | |
| Nitric Acid SCHEMBL28220993 | 0.73 | CDK1 (0.51) | PDPK1GDAPIN1BRAFCYP1A2 | |
| SCHEMBL3038174 | 0.72 | ADORA2A (0.59) | PDPK1GDAPIN1BRAFCYP1A2 | |
| SCHEMBL16147160 | 0.72 | ALPL (0.50) | PDPK1GDACDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030187261-A1 | Purine derivatives, process for their preparation and use thereof | USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) | 2003-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187261-A1 | Purine derivatives, process for their preparation and use thereof | DCK, DTYMK, CCNK | PDPK1 64/4885GDA 148/4885PIN1 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.